ALDA PHARMACEUTICALS CORP. ("APH")
BULLETIN TYPE: Consolidation, Remain Suspended
BULLETIN DATE: March 7, 2012
TSX Venture Tier 2 Company
Pursuant to a special resolution passed by shareholders January 27, 2012, the Company has consolidated its capital on a 10 old for 1 new basis and has subsequently increased its authorized capital. The name of the Company has not been changed.
Effective at the opening, Thursday, March 8, 2012, the shares of ALDA Pharmaceuticals Corp. will be listed on TSX Venture Exchange on a consolidated basis; however, the shares of the Company will remain suspended from trading. The Company is classified as a 'Developing, manufacturing and selling infection control products' company.
Post - Consolidation
Capitalization: Unlimited shares with no par value of which
6,399,680 shares are issued and outstanding
Escrow: Nil shares are subject to escrow
Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: APH (UNCHANGED)
CUSIP Number: 01407W 20 5 (new)
